Publications for Peter Shaw
Publications for Peter Shaw
2016
Koyyalamudi, S., Kuzhiumparambil, U., Nath,
C., Byrne, J., Fraser, C., O'Brien, T., Earl, J.,
Shaw, P. (2016). Development and Validation of
a High Pressure Liquid Chromatography-UV
Method for the Determination of Treosulfan and
Its Epoxy Metabolites in Human Plasma and Its
Application in Pharmacokinetic Studies. Journal
of Chromatographic Science, 54(3), 326-333. <a
href="http://dx.doi.org/10.1093/chromsci/bmv14
5">[More Information]</a>
2015
Bogg, T., Broderick, C., Shaw, P., Cohn, R.,
Naumann, F. (2015). Feasibility of an inpatient
exercise intervention for children undergoing
hematopoietic stem cell transplant. Pediatric
Transplantation, 19(8), 925-931. <a
href="http://dx.doi.org/10.1111/petr.12614">[M
ore Information]</a>
Sutton, R., Shaw, P., Venn, N., Law, T.,
Dissanayake, A., Kilo, T., Haber, M., Norris, M.,
Fraser, C., Alvaro, F., et al (2015). Persistent
MRD before and after allogeneic BMT predicts
relapse in children with acute lymphoblastic
leukaemia. British Journal of Haematology,
168(3), 395-404. <a
href="http://dx.doi.org/10.1111/bjh.13142">[Mo
re Information]</a>
Bogg, T., Shaw, P., Cohn, R., Wakefield, C.,
Hardy, L., Broderick, C., Naumann, F. (2015).
Physical activity and screen-time of childhood
haematopoietic stem cell transplant survivors.
Acta Paediatrica, 104(10), e455-e459. <a
href="http://dx.doi.org/10.1111/apa.13120">[Mo
re Information]</a>
2014
Shaw, P., Nath, C., Lazarus, H. (2014). Not too
little, not too much-just right! (Better ways to
give high dose melphalan). Bone Marrow
Transplantation, 49, 1457-1465. <a
href="http://dx.doi.org/10.1038/bmt.2014.186">[
More Information]</a>
Karski, E., Dvorak, C., Leung, W., Miller, W.,
Shaw, P., Qayed, M., Katsanis, E., Feusner, J.
(2014). Treatment of Hepatoblastoma With
High-dose Chemotherapy and Stem Cell Rescue:
The Pediatric Blood and Marrow Transplant
Consortium Experience and Review of the
Literature. Journal of Pediatric Hematology /
Oncology, 36(5), 362-368. <a
href="http://dx.doi.org/10.1097/MPH.000000000
0000130">[More Information]</a>
2013
Hale, G., Arora, M., Ahn, K., He, W., Camitta,
B., Bishop, M., Bitan, M., Cairo, M., Chan, K.,
Childs, R., et al (2013). Allogeneic
hematopoietic cell transplantation for
neuroblastoma: the CIBMTR experience. Bone
Marrow Transplantation, 48(8), 1056-1064. <a
href="http://dx.doi.org/10.1038/bmt.2012.284">[
More Information]</a>
Clancy, L., Blyth, E., Simms, R., Micklethwaite,
K., Ma, C., Burgess, J., Antonenas, V., Shaw, P.,
Gottlieb, D. (2013). Cytomegalovirus-specific
cytotoxic T lymphocytes can be efficiently
expanded from granulocyte colony-stimulating
factor-mobilized hemopoietic progenitor cell
products ex vivo and safely transferred to stem
cell transplantation recipients to facilitate
immune reconstitution. Biology of Blood and
Marrow Transplantation, 19(5), 725-734. <a
href="http://dx.doi.org/10.1016/j.bbmt.2013.01.0
21">[More Information]</a>
Blyth, E., Clancy, L., Simms, R., Ma, C.,
Burgess, J., Deo, S., Byth Wilson, K., Dubosq,
M., Shaw, P., Micklethwaite, K., Gottlieb, D.
(2013). Donor-derived CMV specific T-cells
reduce the requirement for CMV-directed
pharmacotherapy after allogeneic stem cell
transplantation. Blood, 121(18), 3745-3758. <a
href="http://dx.doi.org/10.1182/blood-2012-08-4
48977">[More Information]</a>
Savic, R., Cowan, M., Dvorak, C., Pai, S.,
Pereira, L., Bartelink, I., Boelens, J., Bredius, R.,
Wynn, R., Cuvelier, G., et al (2013). Effect of
weight and maturation on busulfan clearance in
infants and small children undergoing
hematopoietic cell transplantation. Biology of
Blood and Marrow Transplantation, 19(11),
1608-1614. <a
href="http://dx.doi.org/10.1016/j.bbmt.2013.08.0
14">[More Information]</a>
Garcia, M., Chapman, J., Shaw, P., Gottlieb, D.,
Ralph, A., Craig, J., Tong, A. (2013).
Motivations, experiences, and perspectives of
bone marrow and peripheral blood stem cell
donors: thematic synthesis of qualitative studies.
Biology of Blood and Marrow Transplantation,
19(7), 1046-1058. <a
href="http://dx.doi.org/10.1016/j.bbmt.2013.04.0
12">[More Information]</a>
Mitchell, R., Nivison-Smith, I., Anazodo, A.,
Tiedemann, K., Shaw, P., Teague, L., Fraser, C.,
Carter, T., Tapp, H., Alvaro, F., et al (2013).
Outcomes of haematopoietic stem cell
transplantation for inherited metabolic disorders:
A report from the Australian and New Zealand
Children's Haematology Oncology Group and
the Australasian Bone Marrow Transplant
Recipient Registry. Pediatric Transplantation,
17(6), 582-588. <a
href="http://dx.doi.org/10.1111/petr.12109">[M
ore Information]</a>
Publications for Peter Shaw
Mitchell, R., Nivison-Smith, I., Anazodo, A.,
Tiedemann, K., Shaw, P., Teague, L., Fraser, C.,
Carter, T., Tapp, H., Alvaro, F., et al (2013).
Outcomes of hematopoietic stem cell
transplantation in primary immunodeficiency: a
report from the Australian and New Zealand
Children's Haematology Oncology Group and
the Australasian Bone Marrow Transplant
Recipient Registry. Biology of Blood and
Marrow Transplantation, 19(3), 338-343. <a
href="http://dx.doi.org/10.1016/j.bbmt.2012.11.6
19">[More Information]</a>
2012
Seale, H., Trung, L., Mackie, F., Kennedy S E,
S., Boros, C., Marshall, H., Tidswell, J., Shaw,
P., Montgomery, K., MacIntyre, C. (2012). A
qualitative study investigating knowledge and
attitudes regarding human papillomavirus (HPV)
and the HPV vaccine among parents of
immunosuppressed children. Vaccine, 30(49),
7027-7031. <a
href="http://dx.doi.org/10.1016/j.vaccine.2012.0
9.066">[More Information]</a>
Bartelink, I., Boelens, J., Bredius, R., Egberts,
A., Wang, C., Bierings, M., Shaw, P., Nath, C.,
Hempel, G., Zwaveling, J., et al (2012). Body
Weight-Dependent Pharmacokinetics of
Busulfan in Paediatric Haematopoietic Stem Cell
Transplantation Patients: Towards Individualized
Dosing. Clinical Pharmacokinetics, 51(5),
331-345. <a
href="http://dx.doi.org/10.2165/11598180-00000
0000-00000">[More Information]</a>
Sillence, D., Waters, K., Donaldson, S., Shaw,
P., Ellaway, C. (2012). Combined Enzyme
Replacement Therapy and Hematopoietic Stem
Cell Transplantation in Mucopolysacharidosis
Type VI. In Society for the Study of Inborn
Errors of Metabolism (Eds.), JIMD Reports Case and Research Reports, 2011/2, (pp.
103-106). Heidelberg: Springer.
2011
Hsieh, S., Hibbert, S., Shaw, P., Ahern, V.,
Arora, M. (2011). Association of
Cyclophasophamide Use with Dental
Developmental Defects and Salivary Gland
Dysfunction in Recipients of Childhood
Antineoplastic Therapy. Cancer, 117(10),
2219-2227. <a
href="http://dx.doi.org/10.1002/cncr.25704">[M
ore Information]</a>
Mehr, S., Kakakios, A., Shaw, P., Webster, R.,
Kemp, A. (2011). Beware the lymphopenia: A
case of severe combined immunodeficiency.
Journal of Paediatrics and Child Health, 47(8),
565-567. <a
href="http://dx.doi.org/10.1111/j.1440-1754.201
0.01870.x">[More Information]</a>
Ladenstein, R., Potschger, U., Siabalis, D.,
Garaventa, A., Bergeron, C., Lewis, I., Stein, J.,
Kohler, J., Shaw, P., Holter, W., et al (2011).
Dose Finding Study for the Use of Subcutaneous
Recombinant Interleukin-2 to Augment Natural
Killer Cell Numbers in an Outpatient Setting for
Stage 4 Neuroblastoma After Megatherapy and
Autologous Stem-Cell Reinfusion. Journal of
Clinical Oncology, 29(4), 441-448. <a
href="http://dx.doi.org/10.1200/JCO.2009.23.54
65">[More Information]</a>
Park, J., Scott, J., Stewart, C., London, W.,
Naranjo, A., Santana, V., Shaw, P., Cohn, S.,
Matthay, K. (2011). Pilot Induction Regimen
Incorporating Pharmacokinetically Guided
Topotecan for Treatment of Newly Diagnosed
High-Risk Neuroblastoma: A Children's
Oncology Group Study. Journal of Clinical
Oncology, 29(33), 4351-4357. <a
href="http://dx.doi.org/10.1200/JCO.2010.34.32
93">[More Information]</a>
2010
Suryani, S., Fulcher, D., Nanan, B., Nanan, R.,
Wong, M., Shaw, P., Gibson, J., Williams, A.,
Tangye, S. (2010). Differential expression of
CD21 identifies developmentally and
functionally distinct subsets of human
transitional B cells. Blood, 115(3), 519-529. <a
href="http://dx.doi.org/10.1182/blood-2009-07-2
34799">[More Information]</a>
Hale, K., Shaw, P., Dalla-Pozza, L., MacIntyre,
C., Isaacs, D., Sorrell, T. (2010). Epidemiology
of paediatric invasive fungal infections and a
case-control study of risk factors in acute
leukaemia or post stem cell transplant. British
Journal of Haematology, 149(2), 263-272. <a
href="http://dx.doi.org/10.1111/j.1365-2141.200
9.08072.x">[More Information]</a>
Shaw, P., Kan, F., Ahn, K., Spellman, S., Aljurf,
M., Ayas, M., Burke, M., Cairo, M., Chen, A.,
Davies, S., et al (2010). Outcomes of pediatric
bone marrow transplantation for leukemia and
myelodysplasia using matched sibling,
mismatched related, or matched unrelated
donors. Blood, 116(19), 4007-4015. <a
href="http://dx.doi.org/10.1182/blood-2010-01-2
61958">[More Information]</a>
Nath, C., Shaw, P., Trotman, J., Zeng, L.,
Duffull, S., Hegarty, G., McLachlan, A., Gurney,
H., Kerridge, I., Kwan, Y., Joshua, D., et al
(2010). Population pharmacokinetics of
melphalan in patients with multiple myeloma
undergoing high dose therapy. British Journal of
Clinical Pharmacology, 69(5), 484-497. <a
href="http://dx.doi.org/10.1111/j.1365-2125.201
0.03638.x">[More Information]</a>
Zeng, L., Blair, E., Nath, C., Shaw, P., Earl, J.,
Stephen, K., Montgomery, K., Coakley, J.,
Publications for Peter Shaw
Hodson, E., Stormon, M., McLachlan, A. (2010).
Population pharmacokinetics of mycophenolic
acid in children and young people undergoing
blood or marrow and solid organ transplantation.
British Journal of Clinical Pharmacology, 70(4),
567-579. <a
href="http://dx.doi.org/10.1111/j.1365-2125.201
0.03734.x">[More Information]</a>
K., Earl, J., Coakley, J., McLachlan, A. (2009).
Population Pharmacokinetics of Acyclovir in
Children and Young People with Malignancy
after Administration of Intravenous Acyclovir or
Oral Valacyclovir. Antimicrobial Agents and
Chemotherapy, 53(7), 2918-2927. <a
href="http://dx.doi.org/10.1128/AAC.01138-08"
>[More Information]</a>
2009
Pulsipher, M., Boucher, K., Wall, D., Frangoul,
H., Duval, M., Goyal, R., Shaw, P., Haight, A.,
Grimley, M., Grupp, S., et al (2009).
Reduced-intensity allogeneic transplantation in
pediatric patients ineligible for myeloablative
therapy: results of the Pediatric Blood and
Marrow Transplant Consortium Study
ONC0313. Blood, 114(7), 1429-1436. <a
href="http://dx.doi.org/10.1182/blood-2009-01-1
96303">[More Information]</a>
Kilo, T., Shaw, P. (2009). Cord blood
transplantation for paediatric non-malignant
conditions. In Bhattacharya, Niranjan;
Stubblefield, Phillip (Eds.), Frontiers of Cord
Blood Science, (pp. 161-194). London: Springer.
Samuel, G., Strong, K., Kerridge, I., Jordens, C.,
Ankeny, R., Shaw, P. (2009). Establishing the
role of pre-implantation genetic
diagnosis with human leucocyte antigen typing:
what place do "saviour siblings" have in
paediatric
transplantation? Archives of Disease in
Childhood, 94(4), 317-320. <a
href="http://dx.doi.org/10.1136/adc.2008.138529
">[More Information]</a>
Moore, A., Shaw, P., Hallahan, A., Carter, T.,
Kilo, T., Nivison-Smith, I., O'Brien, T., Tapp,
H., Teague, L., Wilson, S., et al (2009).
Haemopoietic stem cell transplantation for
children in Australia and New Zealand,
1998-2006: a report on behalf of the Australasian
Bone Marrow Transplant Recipient Registry and
the Australian and New Zealand Children's
Haematology Oncology Group. Medical Journal
of Australia, 190(3), 121-125. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19203307">[More Information]</a>
Zeng, L., Nath, C., Shaw, P., Earl, J.,
McLachlan, A. (2009). HPLC-UV assay for
monitoring total and unbound mycophenolic acid
concentrations in children. Biomedical
Chromatography, 23(1), 92-100. <a
href="http://dx.doi.org/10.1002/bmc.1088">[Mo
re Information]</a>
Petterson, T., Gabriel, M., Tiedermann, K.,
Teague, L., Shaw, P., Baker, D., Bolton-Jones,
R., Tapp, H., Oswald, C., Vowels, M., et al
(2009). Outcome following unrelated cord blood
transplant in 136 patients with malignant and
non-malignant diseases: a report from the
Australian and New Zealand children''s
haematology and oncology group. Bone Marrow
Transplantation, 43, 207-215. <a
href="http://dx.doi.org/10.1038/bmt.2008.314">[
More Information]</a>
Zeng, L., Nath, C., Blair, E., Shaw, P., Stephen,
Gea-Banacloche, J., Masur, H., da Cuhna, C.,
Chiller, T., Kirchoff, L., Shaw, P., Tomblyn, M.,
Cordonnier, C. (2009). Regionally limited or rare
infections: prevention after hematopoietic cell
transplantation. Bone Marrow Transplantation,
44(8), 489-494. <a
href="http://dx.doi.org/10.1038/bmt.2009.260">[
More Information]</a>
Bhadri, V., Lee-Horn, L., Shaw, P. (2009).
Safety and tolerability of cidofovir in high-risk
pediatric patients. Transplant infectious disease :
an official journal of the Transplantation
Society, 11(4), 373-9. <a
href="http://dx.doi.org/10.1111/j.1399-3062.200
9.00391.x">[More Information]</a>
2008
Ozkaynak, M., Sahdev, I., Gross, T., Levine, J.,
Cheerva, A., Richards, M., Rozans, M., Shaw,
P., Kadota, R. (2008). A pilot study of addition
of amifostine to melphalan, carboplatin,
etoposide, and cyclophosphamide with
autologous hematopoietic stem cell
transplantation in pediatric solid tumors - A
pediatric blood and marrow transplant
consortium study. Journal of Pediatric
Hematology / Oncology, 30(3), 204-209. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18376282">[More Information]</a>
Alexander, S., Smith, N., Hu, M., Verran, D.,
Shun, A., Dorney, S., Smith, A., Webster, B.,
Shaw, P., Lammi, A., Stormon, M. (2008).
Chimerism and Tolerance in a Recipient of a
Deceased-Donor Liver Transplant. New England
Journal of Medicine, 358(4), 369-374. <a
href="http://dx.doi.org/10.1056/NEJMoa070725
5">[More Information]</a>
Strong, K., Kerridge, I., Jordens, C., Ankeny, R.,
Shaw, P., O'Brien, T., Carter, S.,
Barlow-Stewart, K. (2008). Creating 'Saviour
Publications for Peter Shaw
Siblings' for transplantation-discrepancy between
parental wishes and clinical practice. 50th
American Society of Hematology Annual
Meeting and Exposition ASH 2008, United
States: American Society of Hematology.
Neuroendocrine Tumors. Seminars in Nuclear
Medicine, 37(4), 286-302. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17544628">[More Information]</a>
Khan, N., Cisterne, A., Devidas, M., Shuster, J.,
Hunger, S., Shaw, P., Bradstock, K., Bendall, L.
(2008). Expression of CD44, but not CD44v6,
predicts relapse in children with B cell
progenitor acute lymphoblastic leukemia lacking
adverse or favorable genetics. Leukemia and
Lymphoma, 49(4), 710-718. <a
href="http://dx.doi.org/10.1080/1042819070186
1660">[More Information]</a>
Nath, C., Shaw, P., Trotman, J., Zhang, Y.
(2007). Pharmacokinetics of melphalan in
myeloma patients undergoing an autograft. Bone
Marrow Transplantation, 40(7), 707-8. <a
href="http://dx.doi.org/10.1038/sj.bmt.1705797"
>[More Information]</a>
Zeng, L., Nath, C., Shaw, P., Earl, J.,
McLachlan, A. (2008). HPLC-fluorescence assay
for acyclovir in children. Biomedical
Chromatography, 22(8), 879-887. <a
href="http://dx.doi.org/10.1002/bmc.1006">[Mo
re Information]</a>
Hong, Y., Shaw, P., Tattam, B., Nath, C., Earl,
J., Stephen, K., McLachlan, A. (2007). Plasma
protein distribution and its impact on
pharmacokinetics of liposomal amphotericin B in
paediatric patients with malignant diseases.
European Journal of Clinical Pharmacology,
63(2), 165-172. <a
href="http://dx.doi.org/10.1007/s00228-006-024
0-x">[More Information]</a>
Nath, C., Earl, J., Pati, N., Stephen, K., Shaw, P.
(2008). Variability in the pharmacokinetics of
intravenous busulphan given as a single daily
dose to paediatric blood or marrow transplant
recipients. British Journal of Clinical
Pharmacology, 66(1), 50-59. <a
href="http://dx.doi.org/10.1111/j.1365-2125.200
8.03166.x">[More Information]</a>
Nath, C., Shaw, P., Montgomery, K., Earl, J.
(2007). Population pharmacokinetics of
melphalan in paediatric blood or marrow
transplant recipients. British Journal of Clinical
Pharmacology, 64(2), 151-164. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17324241">[More Information]</a>
2007
2006
Nath, C., McLachlan, A., Shaw, P., Coakley, J.,
Earl, J. (2007). Amphotericin B Dose
Optimization in Children with Malignant
Diseases. Chemotherapy, 53(2), 142-147. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17310120">[More Information]</a>
Park, J., Stewart, C., London, W., Santana, V.,
Shaw, P., Cohn, S., Matthay, K. (2006). A
topotecan-containing induction regimen for
treatment of high risk neuroblastoma. 2006
American Society of Clinical Oncology (ASCO)
Annual Meeting, United States: American
Society of Clinical Oncology.
Nath, C., Shaw, P. (2007). Busulphan in blood
and marrow transplantation: dose, route,
frequency and role of therapeutic drug
monitoring. Current Clinical Pharmacology,
2(1), 75-91. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18690856">[More Information]</a>
Kakakios, A., Tugwell, H., Shaw, P. (2006).
Allogeneic bone marrow transplantation with
reduced intensity conditioning for chronic
granulomatous disease complicated by invasive
Aspergillus infection. Pediatric Blood & Cancer,
47, 327-9. <a
href="http://dx.doi.org/10.1002/pbc.20865">[Mo
re Information]</a>
Micklethwaite, K., Hansen, A., Foster, A.,
Snape, E., Antonenas, V., Sartor, M., Shaw, P.,
Bradstock, K., Gottlieb, D. (2007). Ex vivo
expansion and prophylactic infusion of
CMV-pp65 peptide-specific cytotoxic
T-lymphocytes following allogeneic
hematopoietic stem cell transplantation. Biology
of Blood and Marrow Transplantation, 13(6),
707-714. <a
href="http://dx.doi.org/10.1016/j.bbmt.2007.02.0
04">[More Information]</a>
Antonenas, V., Bradstock, K., Shaw, P., Gottlieb,
D. (2006). Comparison between TNC and
CD34+cell counts reported pre-cryopreservation
of unrelated cord blood (UCB) units and those
observed at the time of their transplantation.
2nd International Conference 'Strategies in
Tissue Engineering', United Kingdom: Informa
Healthcare.
Howman-Giles, R., Shaw, P., Uren, R., Chung,
D. (2007). Neuroblastoma and Other
Cuss, A., Avery, D., Cannons, J., Yu, L.,
Nichols, K., Shaw, P., Tangye, S. (2006).
Expansion of functionally immature transitional
B cells is associated with
human-immunodeficient states characterized by
Publications for Peter Shaw
impaired humoral immunity. The Journal of
Immunology, 176(3), 1506-1516. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16424179">[More Information]</a>
Petterson, T., Tiedemann, K., Teague, L., Shaw,
P., Baker, D., Bolton-Jones, R., Oswald, C.,
O'Brien, T. (2006). Outcome following unrelated
cord blood transplant in 136 patients with
malignant and non-malignant diseases: A report
from the Australian and New Zealand children's
haematology and oncology group (anzchog).
32nd Annual Meeting of the American Society
for Blood and Marrow Transplantation, United
States: Elsevier Ltd.
Bateman, C., Kesson, A., Shaw, P. (2006).
Pancreatitis and adenoviral infection in children
after blood and marrow transplantation. Bone
Marrow Transplantation, 38(12), 807-811. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17057728">[More Information]</a>
Gandhi, M., Lambley, E., Burrows, J., Dua, U.,
Elliott, S., Shaw, P., Prince, H., Wolf, M.,
Clarke, K., Underhill, C., et al (2006). Plasma
Epstein-Barr virus (EBV) DNA is a biomarker
for EBV-positive Hodgkin's lymphoma. Clinical
Cancer Research, 12(2), 460-464.
Hong, Y., Shaw, P., Nath, C., Yadav, S.,
Stephen, K., Earl, J., McLachlan, A. (2006).
Population pharmacokinetics of liposomal
amphotericin B in pediatric patients with
malignant diseases. Antimicrobial Agents and
Chemotherapy, 50(3), 935-942. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16495254">[More Information]</a>
Halliday, C., Hoile, R., Sorrell, T., James, G.,
Yadav, S., Shaw, P., Bleakley, M., Bradstock,
K., Chen, S. (2006). Role of prospective
screening of blood for invasive aspergillosis by
polymerase chain reaction in febrile neutropenic
recipients of haematopoietic stem cell transplants
and patients with acute leukaemia. British
Journal of Haematology, 132(4), 478-486. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16412020">[More Information]</a>
Stephen, K., Montgomery, K., Bateman, C.,
Calandra, G., Shaw, P. (2006). Successful
mobilisation, harvest, and transplant of stem cells
following AMD3100 in 3 paediatric patients.
The Australian experience. 32nd Annual Meeting
of the American Society for Blood and Marrow
Transplantation, United States: Elsevier Ltd.
2005
Spavor, M., Ahern, V., Shaw, P., Steinbeck, K.,
Somerville, E., Somerville, H. (2005). Beyond
brain tumours and cognition: Neurological
complications in long-term survivors of
childhood non-central nervous system
malignancies. 26th International Epilepsy
Congress (IEC), United States: Blackwell
Publishers.
Nath, C., Shaw, P., Montgomery, K., Earl, J.
(2005). Melphalan pharmacokinetics in children
with malignant disease: influence of body
weight, renal function, carboplatin therapy and
total body irradiation. British Journal of Clinical
Pharmacology, 59(3), 314-324. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15752378">[More Information]</a>
2004
Shaw, P., Nath, C., Berry, A., Earl, J. (2004).
Busulphan Given As Four Single Daily Doses Of
150 Mg/M2 Is Safe And Effective In Children Of
All Ages. Bone Marrow Transplantation, 34(3),
197-205.
Antonenas, V., Kerridge, I., Thomson, A.,
Trickett, A., Shaw, P., Bradstock, K. (2004).
Development of a policy for the storage and
disposal of cryopreserved haematopoietic
progenitor cells for the NSW BMT Network
Laboratories. Australian and New Zealand
Transplant Society.
Gluckman, E., Shaw, P., Arcese, W., Michel, G.,
Sanz, G., Chan, K., Takahashi, T., Ortega, J.,
Filipovich, A., Locatelli, F., et al (2004). Factors
Associated With Outcomes Of Unrelated Cord
Blood Transplant: Guidelines For Donor Choice.
Experimental Hematology, 32(4), 397-407. <a
href="http://dx.doi.org/10.1016/j.exphem.2004.0
1.002">[More Information]</a>
Antonenas, V., Shaw, P., Bradstock, K. (2004).
Letter: Infusion of unwashed umbilical cord
blood stem cells after thawing for allogeneic
transplantation. Bone Marrow Transplantation,
34(8), 739.
Barbaric, D., Curtin, J., Pearson, L., Shaw, P.
(2004). Role Of Hydrochloric Acid In The
Treatment Of Central Venous Catheter Infections
In Children With Cancer. Cancer, 101(8),
1866-1872. <a
href="http://dx.doi.org/10.1002/cncr.20562">[M
ore Information]</a>
2003
Locatelli, F., Labopin, M., Ortega, J., Meloni, G.,
Dini, G., Messina, C., Yaniv, I., Fagioli, F.,
Castel, V., Shaw, P., et al (2003). Factors
influencing outcome and incidence of long-term
complications in children who underwent
autologous stem cell transplantation for acute
myeloid leukemia in first complete remission.
Publications for Peter Shaw
Blood, 101(4), 1611-1619.
Michel, G., Rocha, V., Chevret, S., Arcese, W.,
Chan, K., Filipovich, A., Takahashi, T., Vowels,
M., Ortega, J., Bordigoni, P., Shaw, P., et al
(2003). Unrelated cord blood transplantation for
childhood acute myeloid leukemia: a Eurocord
Group Analysis. Blood, 102(13), 4290-4297.
2002
Milledge, J., Shaw, P., Mansour, A., Williamson,
S., Bennetts, B., Roscioli, T., Curtin, J.,
Christodoulou, J. (2002). Allogeneic bone
marrow transplantation: cure for familial
Mediterranean fever. Blood, 100(3), 774-777.
Smith, A., Shaw, P., Webster, B., Lammi, A.,
Gaskin, K., Diaz, S., Sharma, P. (2002).
Intermittent 20q- and consistent i(7q) in a patient
with Shwachman-Diamond syndrome. Pediatric
Hematology and Oncology, 19(7), 525-528.